In order to continue to be viable in the next decade, the pharmaceutical industry is adapting in ways that might seem surprising just a few years ago. The pressure to reduce costs coupled with the need to be more innovative and still comply with U.S. Food and Drug Administration regulations has led to a number of new developments.
Disruptive technology, big data, demographic trends and healthcare reform are impacting the kind of decisions pharmaceutical companies make about drug development. A PriceWaterhouseCoopers report Pharma 2020: from vision to decision outlines the trends and opportunities that will help define the pharmaceutical industry and the challenges it will face implementing them.
To read the original article: 8 things pharmaceutical companies can do to ensure their survival | MedCity News
